Terence Ching, PhD

Terence Ching (he/him) is a licensed clinical psychologist and associate research scientist in the Department of Psychiatry. Terence co-leads psilocybin clinical trials for OCD and other disorders as part of the Yale OCD Research Clinic/Emerging and Novel Applications for Consciousness-Altering Therapeutics (ENACT) Lab and the Yale Program for Psychedelic Science, under the mentorship of Benjamin Kelmendi, MD, and Christopher Pittenger, MD, PhD.

Terence received his PhD in clinical psychology from the University of Connecticut. Prior to moving to the United States, Terence received his Bachelor’s and Master’s degrees in psychology from the National University of Singapore.

He has interests and expertise in: (1) fear-/trauma-based disorders (OCD, anxiety disorders, PTSD); (2) exposure-based, integrative cognitive-behavior therapies (CBT); (3) culturally attuned care; and (4) therapeutic applications of psychedelics.

Terence has completed clinical training in a variety of settings, including the University of Connecticut, the Institute of Living, as well as Dartmouth-Hitchcock Medical Center. Terence approaches psychotherapy from an evidence-based and culturally attuned perspective, and specializes in exposure-based CBT for fear-/trauma-based disorders. Terence has also received training in functional analytic psychotherapy (FAP).

Additionally, Terence is a MAPS-certified psychedelic therapist in MDMA-assisted therapy (MDMA-AT) for PTSD. Further, Terence has experience providing ketamine-assisted psychotherapy (KAP) for individuals with depressive and anxiety disorders, and PTSD.